Cobalt−NHC Catalyzed C(sp 2 )−C(sp 3 ) and C(sp 2 )−C(sp 2 ) Kumada Cross‐Coupling of Aryl Tosylates with Alkyl and Aryl Grignard Reagents

Cobalt-N-Heterocyclic Carbene Complexes in Catalysis

Cobalt-NHC complexes have emerged as an attractive class of 3d transition metal catalysts for a broad range of chemical processes, including cross-coupling, hydrogenation, hydrofunctionalization and cycloaddition reactions. Herein, we present a comprehensive review of catalytic methods utilizing cobalt-NHC complexes with a focus on catalyst structure, the role of the NHC ligand, properties of the catalytic system, mechanism and synthetic utility. The survey clearly suggests that the recent emergence of well-defined cobalt-NHC catalysts may have a tremendous utility in the design and application of catalytic reactions using more abundant 3d transition metals.

Iron-Catalyzed Cross-Coupling Reactions of Alkyl Grignards with Aryl Chlorobenzenesulfonates

Aryl sulfonate esters are versatile synthetic intermediates in organic chemistry as well as attractive architectures due to their bioactive properties. Herein, we report the synthesis of alkyl-substituted benzenesulfonate esters by iron-catalyzed C(sp2)-C(sp3) cross-coupling of Grignard reagents with aryl chlorides. The method operates using an environmentally benign and sustainable iron catalytic system, employing benign urea ligands. A broad range of chlorobenzenesulfonates as well as challenging alkyl organometallics containing β-hydrogens are compatible with these conditions, affording alkylated products in high to excellent yields. The study reveals that aryl sulfonate esters are the most reactive activating groups for iron-catalyzed alkylative C(sp2)-C(sp3) cross-coupling of aryl chlorides with Grignard reagents.

On the application of 3d metals for C-H activation toward bioactive compounds: The key step for the synthesis of silver bullets

Several valuable biologically active molecules can be obtained through C-H activation processes. However, the use of expensive and not readily accessible catalysts complicates the process of pharmacological application of these compounds. A plausible way to overcome this issue is developing and using cheaper, more accessible, and equally effective catalysts. First-row transition (3d) metals have shown to be important catalysts in this matter. This review summarizes the use of 3d metal catalysts in C-H activation processes to obtain potentially (or proved) biologically active compounds.